한국유니온제약
080720KOSDAQ58.0 / 100
Reference Date: 2026-10-23
Company InformationBased on 2025 Annual Report
Business Overview
Korea Union Pharmaceutical focuses on manufacturing and selling specialty pharmaceuticals, exporting finished drugs, and providing CMO (contract manufacturing) services. The company specializes in antibiotics, cardiovascular, and musculoskeletal products, leveraging its GMP facilities and R&D efforts to enhance profitability. It has expanded exports to regions such as the Middle East, Southeast Asia, and South America, and is further expanding its CMO business and product portfolio through a newly completed factory.
Number of Employees
123people
Average Salary
39.2M KRW
Score Calculation Basis
Detailed Financial Score
52.4x industry avg (excellent)
Half of industry avg (excellent)
Avg ▼23.9% (2-year basis)
Avg ▼92.6% (2-year basis)
Avg ROE 88.4% (improving, 3yr)
Detailed News Sentiment
Detailed Momentum
Near 52w low (0%, downtrend)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral주요사항보고서(감자결정)2026-10-21
- Positive주요사항보고서(유상증자결정)2026-10-21
- Neutral[기재정정]반기보고서 (2026.06)2026-10-12
- Neutral상호변경안내2026-10-08
- Neutral임시주주총회결과2026-10-08
